Exchange Traded Concepts’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-34,152
Closed -$92.2K 1448
2025
Q1
$92.2K Sell
34,152
-31,778
-48% -$119K ﹤0.01% 1186
2024
Q4
$156K Hold
65,930
﹤0.01% 1049
2024
Q3
$156K Buy
65,930
+31,047
+89% +$68.3K ﹤0.01% 1056
2024
Q2
$68K Sell
34,883
-10,853
-24% -$36.9K ﹤0.01% 967
2024
Q1
$294K Buy
45,736
+39,535
+638% +$359K 0.01% 802
2023
Q4
$86.9K Buy
6,201
+1,573
+34% +$24.8K ﹤0.01% 902
2023
Q3
$113K Buy
4,628
+186
+4% +$4.71K ﹤0.01% 859
2023
Q2
$145K Buy
+4,442
New +$125K ﹤0.01% 848

Other funds holding GNLX

Exchange Traded Concepts's GNLX Position: Q2 2025 in Review

Exchange Traded Concepts sold out of Genelux (GNLX) in Q2 2025, closing a stake of 34,152 shares — an estimated $92.2K sold.

Exchange Traded Concepts first reported a position in GNLX in Q2 2023 and held it in 8 quarters. The position peaked at $294K in Q1 2024. 61 funds tracked by Wall St. Rank hold GNLX as of Q2 2025.

  • Exchange Traded Concepts reported no remaining Genelux position as of Q2 2025 after selling out during the quarter.
  • Exchange Traded Concepts sold 34,152 Genelux shares in Q2 2025, an estimated $92.2K.
  • Exchange Traded Concepts first reported a position in Genelux in Q2 2023 and held it in 8 quarters.
  • Exchange Traded Concepts's Genelux position peaked at $294K in Q1 2024.
  • 61 funds tracked by Wall St. Rank held Genelux as of Q2 2025.

Based on Exchange Traded Concepts's 13F filing for Q2 2025, filed 10 Jul 2025.